Taiyen Biotech Co., Ltd. (TPE:1737)
Taiwan
· Delayed Price · Currency is TWD 31.80
+0.10 (0.32%)
Apr 29, 2026, 1:30 PM CST
Taiyen Biotech Revenue
In the year 2025, Taiyen Biotech had annual revenue of 3.31B TWD with 2.15% growth. Taiyen Biotech had revenue of 816.45M in the quarter ending December 31, 2025, with 4.38% growth.
Revenue
3.31B
Revenue Growth
+2.15%
P/S Ratio
1.92
Revenue / Employee
7.35M
Employees
450
Market Cap
6.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.31B | 69.51M | 2.15% |
| Dec 31, 2024 | 3.24B | -170.66M | -5.01% |
| Dec 31, 2023 | 3.41B | -204.80M | -5.67% |
| Dec 31, 2022 | 3.61B | -482.04M | -11.77% |
| Dec 31, 2021 | 4.10B | 965.30M | 30.84% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chlitina Holding | 3.88B |
| Dr. Wu Skincare | 1.17B |
| Yuen Foong Yu Consumer Products | 10.65B |
| Shiny Brands Group | 3.29B |
| Farcent Enterprise Co.,Ltd | 2.41B |
| Shihlin Paper | 153.29M |
| TCI Co., Ltd. | 6.99B |
| Nan Liu Enterprise | 6.61B |